Literature DB >> 19933624

18F-FDG PET/CT of transitional cell carcinoma.

Vivek V Patil1, Zhen J Wang, Richard A Sollitto, Kai-Wen Chuang, Badrinath R Konety, Randy A Hawkins, Fergus V Coakley.   

Abstract

OBJECTIVE: The objective of this article is to provide a practical illustrated review of PET/CT in the imaging evaluation of transitional cell carcinoma.
CONCLUSION: Local evaluation of the primary tumor in patients with transitional cell carcinoma on PET is often limited by the obscuring effect of excreted FDG, but assessment of metabolic activity may still be possible through close correlation with CT images. PET/CT may also be helpful in the detection of disease outside the bladder at nodal or more distant sites and in the assessment of recurrent disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933624     DOI: 10.2214/AJR.08.1945

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  10 in total

1.  Detection of Thyroid Metastasis of Renal Transitional Cell Carcinoma Using FDG PET/CT.

Authors:  Yong-Il Kim; Jong Jin Lee; Jin Ho Paik; Yu Kyeong Kim; Sang Eun Kim
Journal:  Nucl Med Mol Imaging       Date:  2011-03-22

Review 2.  Molecular imaging of urogenital diseases.

Authors:  Steve Y Cho; Zsolt Szabo
Journal:  Semin Nucl Med       Date:  2014-03       Impact factor: 4.446

3.  Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladder.

Authors:  Henning Reis; Stephan Tschirdewahn; Tibor Szarvas; Herbert Rübben; Kurt Werner Schmid; Florian Grabellus
Journal:  Oncol Lett       Date:  2011-08-29       Impact factor: 2.967

4.  Application of (18)F-FDG PET/CT imaging in diagnosing bladder tumor metastasis lesions.

Authors:  Yang Li; Zhong-Qing Yang; Hui Ye; Lin Qi; Jun-Wu Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-04-17

Review 5.  Update on advances in molecular PET in urological oncology.

Authors:  Kazuhiro Kitajima; Shingo Yamamoto; Kazuhito Fukushima; Ryogo Minamimoto; Takao Kamai; Hossein Jadvar
Journal:  Jpn J Radiol       Date:  2016-05-24       Impact factor: 2.374

6.  Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.

Authors:  Christiaan Schiepers; Magnus Dahlbom
Journal:  Eur Radiol       Date:  2010-12-21       Impact factor: 5.315

Review 7.  Evaluation of lymph node status in patients with urothelial carcinoma-still in search of the perfect imaging modality: a systematic review.

Authors:  Michał Frączek; Hubert Kamecki; Anna Kamecka; Roman Sosnowski; Katarzyna Sklinda; Marcin Czarniecki; Leszek Królicki; Jerzy Walecki
Journal:  Transl Androl Urol       Date:  2018-10

Review 8.  PET-CT and PET-MR in urological cancers other than prostate cancer: An update on state of the art.

Authors:  Abdul Razik; Chandan Jyoti Das; Sanjay Sharma
Journal:  Indian J Urol       Date:  2018 Jan-Mar

9.  Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer.

Authors:  Akinori Nukui; Takahiro Narimatsu; Tsunehito Kambara; Hideyuki Abe; Setsu Sakamoto; Ken-Ichiro Yoshida; Takao Kamai
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

10.  Primary squamous cell carcinoma of the urinary bladder presenting as an inguinal mass.

Authors:  Zahra Qaiyumi; Pankaj Nepal; Christopher Iannuzzi; Joshua Sapire
Journal:  SA J Radiol       Date:  2021-03-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.